Fulltext

Limited capacity of SARS-CoV-2 variants testing in Japan: A secondary analysis using publicly available data

Hashimoto T 1 , Ozaki A 2 , Bhandari D 3 , Sawano T 4 , Murayama A 3 , Shrestha S 5 Show all authors , Sah R 6 , Tanimoto T 7 , Montenegro-Idrogo JJ 8 , Rodriguez-Morales AJ 9

Affiliations 

  • 1 Department of Pharmacy, Sendai City Medical Center, Sendai, Miyagi, Japan
  • 2 Department of Breast Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki, Fukushima, Japan; Medical Governance Research Institute, Tokyo, Japan
  • 3 Medical Governance Research Institute, Tokyo, Japan
  • 4 Department of Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki, Fukushima, Japan
  • 5 School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, 47500, Bandar Sunway, Selangor Darul Ehsan, Malaysia
  • 6 Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal
  • 7 Navitas Clinic Kawasaki, Kanagawa, Japan
  • 8 Service of Infectious and Tropical Diseases, Hospital Nacional Dos de Mayo, Lima, Peru; Master in Clinical Epidemiology and Biostatistics, Universidad Cientifica del Sur, Lima, Peru
  • 9 Master in Clinical Epidemiology and Biostatistics, Universidad Cientifica del Sur, Lima, Peru; Grupo de Investigacion Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Américas, Pereira, Colombia; Universidad Privada Franz Tamayo, Cochabamba, Bolivia. Electronic address: arodriguezmo@cientifica.edu.pe
Travel Med Infect Dis, 2021;43:102145.
PMID: 34298174 DOI: 10.1016/j.tmaid.2021.102145

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications